Skip to Main Content

Paper Details

Gene therapy companies have an ethical obligation to develop expanded access policies.
Mol Ther
9
2021
Author NameAffiliation
Carolyn Riley ChapmanDivision of Medical Ethics, NYU Grossman School of Medicine
Arthur L CaplanDivision of Medical Ethics, NYU Grossman School of Medicine
  • 1 - 2

Datasets